BioCentury
ARTICLE | Company News

OncoMethylome Sciences Inc., Fox Chase Cancer Center deal

June 27, 2005 7:00 AM UTC

The center granted OncoMethylome an exclusive license to IP covering the use of methylation-specific PCR technology and a panel of tumor-suppressor genes to detect ovarian and kidney cancer. ...